APA

Duggan M. E., Duong L. T., Fisher J. E., Hamill T. G., Hoffman W. F., Huff J. R., Ihle N. C., Leu C. T., Nagy R. M., Perkins J. J., Rodan S. B., Wesolowski G., Whitman D. B., Zartman A. E., Rodan G. A. & Hartman G. D. (20001108). Nonpeptide alpha(v)beta(3) antagonists. 1. Transformation of a potent, integrin-selective alpha(IIb)beta(3) antagonist into a potent alpha(v)beta(3) antagonist. : Journal of medicinal chemistry.

Chicago

Duggan M E, Duong L T, Fisher J E, Hamill T G, Hoffman W F, Huff J R, Ihle N C, Leu C T, Nagy R M, Perkins J J, Rodan S B, Wesolowski G, Whitman D B, Zartman A E, Rodan G A and Hartman G D. 20001108. Nonpeptide alpha(v)beta(3) antagonists. 1. Transformation of a potent, integrin-selective alpha(IIb)beta(3) antagonist into a potent alpha(v)beta(3) antagonist. : Journal of medicinal chemistry.

Harvard

Duggan M. E., Duong L. T., Fisher J. E., Hamill T. G., Hoffman W. F., Huff J. R., Ihle N. C., Leu C. T., Nagy R. M., Perkins J. J., Rodan S. B., Wesolowski G., Whitman D. B., Zartman A. E., Rodan G. A. and Hartman G. D. (20001108). Nonpeptide alpha(v)beta(3) antagonists. 1. Transformation of a potent, integrin-selective alpha(IIb)beta(3) antagonist into a potent alpha(v)beta(3) antagonist. : Journal of medicinal chemistry.

MLA

Duggan M E, Duong L T, Fisher J E, Hamill T G, Hoffman W F, Huff J R, Ihle N C, Leu C T, Nagy R M, Perkins J J, Rodan S B, Wesolowski G, Whitman D B, Zartman A E, Rodan G A and Hartman G D. Nonpeptide alpha(v)beta(3) antagonists. 1. Transformation of a potent, integrin-selective alpha(IIb)beta(3) antagonist into a potent alpha(v)beta(3) antagonist. : Journal of medicinal chemistry. 20001108.